The League ended the
2002-2003 Fiscal Year in a strong financial position as a
result of successful epilepsy regional and international
congresses as well as healthy Epilepsia royalties. A preliminary
review of the unaudited 2003-2004 fiscal year financials
indicates another year of favorable financial results.
In an effort to support the League’s goals and mission,
the Finance Committee has developed an investment policy
with the objective of maintaining financial security while
providing funds to continue work towards the advancement
of education and research worldwide.
As illustrated below, the largest revenue source for the
year is represented by Epilepsia royalties. Our official
journal, Epilepsia, has been very successful scientifically
with an increased impact factor. It has also been very successful
with regard to subscriptions, sales and advertising revenue.
Our original international congresses represent the second
largest source of revenue for the League and this is largely
due to the efforts of the office of the International Director
of Meetings (IDM) and its very dedicated staff.
Program services represent the largest League expenditure
at 80% of expenses. These expenditures include costs associated
with the Commissions, Task Forces, Meetings, Programmes (such
as the Global Campaign) and membership services (such as
website development). Administrative expenses account for
20% of expenditure.
The Treasurer’s office is quite happy to discuss any
financial issues relating to the League. The first port of
call is Donna Cunard, our Financial Officer, who is based
at the Hartford office. Mrs. Cunard has done an extremely
valuable job efficiently running our financial affairs, and
I am very grateful for her continued support.